Equity Pricing in the Real World: Moving from Ambiguity to Action for Patients, Payers, and Health Systems Aligning equitable access and commercial sustainability is one of the Read More »
Define Your Value Strategy How a comprehensive catalogue of early and alternative access pathways facilitated accelerated access for patients with rare diseases Read More
Define Your Value Strategy How assessing the pricing and reimbursement risks associated with a product withdrawal supported the action steps to take in key Central and Eastern EU markets Read More
Define Your Value Strategy How a deep-dive analysis of pricing methodologies and access routes in Australia allowed early planning of market access strategies for orphan drugs Read More
Define Your Value Strategy How partnering with local experts helped define third wave launch countries for our client’s geographical expansion Read More
Define Your Value Strategy How i-vbp® enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy Read More
Define Your Value Strategy How a thorough analysis of potential access scenarios allowed the successful launch of a new product indication Read More
Define Your Value Strategy How i-vbp® helped a specialty company pilot a new way of assessing the value of acquisition targets in multiple rare CNS diseases Read More
